Sai Life Sciences
add_icon

Sai Life Sciences

1,140.50
-19.50
(-1.68%)
Market Cap
24,152.16 Cr
PE Ratio
70.53
Volume
3,98,937.00
Day High - Low
1,175.60 - 1,127.10
52W High-Low
1,184.80 - 707.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
24,152.16 Cr
EPS
16.63
PE Ratio
70.53
PB Ratio
9.91
Book Value
117.09
EBITDA
623.16
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
7.99
Debt to Equity
0.41
Analyst Rating and Forecast
- By Refinitiv from5 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Sai Life Sciences scheduled meetings with analysts on June 3-4, 2026. Events include Morgan Stanley and Citi conferences in Mumbai.
positive
Sai Life Sciences filed its Q4FY26 investor presentation on May 15, 2026, highlighting 5-year KPI trends, strategic updates, and FY26 PAT of ₹355 Cr on 29% revenue growth.
positive
Sai Life Sciences' Bidar campus becomes the first Indian CRDMO site to operate on 100% renewable electricity, covering nearly 80% of total organisational energy from renewables.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,799.80
#1 4,31,832.31
37.54
#1 58,220.10
6.38
#1 11,565
25.80
46.23
6,550.50
1,73,895.19
68.85
10,560.00
8.73
2,520
13.44
50.98
4,365.20
1,47,738.20
69.56
13,753.00
19.18
2,028
-26.91
52.33
1,392.20
1,12,459.23
29.25
27,711.70
-2.46
3,783
-55.32
59.75
1,091.30
1,09,810.32
21.16
26,719.70
13.65
5,242
7.82
72.44
1,286.50
1,07,376.82
26.16
33,593.30
-0.44
3,998
-86.05
50.35
2,264.00
1,03,474.58
#1 19.40
27,487.50
19.98
5,345
#1 87.72
45.61
2,321.70
95,840.95
50.66
14,277.60
12.03
1,750
31.75
50.18
1,434.80
83,333.42
23.73
33,384.70
3.21
3,376
1.99
45.43
1,387.00
74,878.11
82.57
6,812.90
#1 21.03
884
21.18
73.71

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
26.64 %
Net Income Growth
122.10 %
Cash Flow Change
19.37 %
ROE
-5.89 %
ROCE
-1.49 %
EBITDA Margin (Avg.)
8.81 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
395
443
288
406
449
589
506
553
565
618
Expenses
287
315
254
293
320
422
376
392
377
426
EBITDA
108
128
34
112
129
167
131
161
188
192
Operating Profit %
25 %
28 %
9 %
26 %
27 %
27 %
24 %
27 %
32 %
29 %
Depreciation
31
31
31
36
34
38
38
40
44
45
Interest
23
21
21
21
23
11
12
9
10
8
Profit Before Tax
53
76
-18
55
72
119
81
112
134
139
Tax
13
20
-5
14
18
31
20
28
34
35
Net Profit
40
56
-14
42
54
88
61
84
100
104
EPS in ₹
2.19
31.00
-0.74
2.22
2.89
4.24
2.90
4.01
4.77
4.93

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
1,216
1,410
1,817
2,157
2,187
2,275
3,160
3,626
Fixed Assets
374
641
701
751
1,037
1,180
1,488
2,085
Current Assets
691
613
804
944
964
945
1,505
1,411
Capital Work in Progress
116
91
246
410
151
107
125
271
Investments
0
0
0
0
2
2
2
151
Other Assets
726
679
870
997
997
987
1,545
0
Total Equity & Liabilities
1,216
1,410
1,817
2,157
2,187
2,275
3,160
3,626
Current Liabilities
336
467
599
713
759
740
733
834
Non Current Liabilities
160
149
356
565
540
560
299
309
Total Equity
720
794
863
879
888
975
2,128
2,484
Reserve & Surplus
703
777
845
861
870
957
2,108
2,463
Share Capital
16
16
18
18
18
18
21
21

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
239
-150
-1
75
-80
-24
79
Investing Activities
-158
-262
-260
-102
-99
-191
-536
Operating Activities
129
116
-36
105
219
263
314
Financing Activities
268
-4
296
72
-201
-95
301

Share Holding

% Holding
Jul 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
39.64 %
35.24 %
35.24 %
35.17 %
35.15 %
34.94 %
34.70 %
34.61 %
FIIs
0.00 %
7.64 %
11.72 %
12.36 %
14.58 %
22.50 %
21.40 %
21.17 %
DIIs
0.00 %
5.61 %
11.95 %
13.26 %
21.64 %
29.91 %
31.41 %
31.54 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
18.68 %
8.88 %
7.69 %
6.56 %
7.91 %
5.95 %
6.13 %
Others
60.36 %
32.84 %
32.22 %
31.52 %
22.07 %
4.74 %
6.54 %
6.56 %
No of Share Holders
70
5,72,970
82
1,40,677
1,26,380
1,19,705
1,14,820
1,17,527

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
06 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2025 695.75 694.80
13 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 May 2025 717.70 713.35
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 815.20 792.85
11 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
11 Sept 2025 791.55 861.70
06 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2025 892.85 923.20
05 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Feb 2026 808.30 810.00
14 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 May 2026 959.40 1,085.40

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation4 days ago
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 21, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 15, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 15, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 15, 2026
Disclosure Of Key Performance Indicators Under SEBI (Issue Of Capital And Disclosure Requirements) Regulations 2018May 14, 2026
Disclosure Of Key Performance Indicators Under SEBI (Issue Of Capital And Disclosure Requirements) Regulations 2018May 14, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 14, 2026
Audited Financial Results For The Year Ended 31 March 2026May 14, 2026
Board Meeting Outcome for Board Meeting Outcome For Approval Of Audited Financial Results For The Financial Year Ending 31.03.2026May 14, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 11, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 11, 2026
Intimation Of An Order Dated 29Th April 2026 Issued By The Joint Commissioner Of Commercial Taxes (Appeals) Kalaburagi U/S 107 (11) Of The Central Goods And Services Tax Act 2017 And The Karnataka Goods And Services Tax Act 2017.Apr 30, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSApr 23, 2026
Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone & Consolidated) For The Fourth Quarter And Year Ended 31 March 2026.Apr 21, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 30, 2026
Closure of Trading WindowMar 30, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 24, 2026
Intimation Of An Order Dated 18Th March 2026 Passed By The Deputy Commissioner Of Income Tax (International Taxation) Hyderabad U/S 201 (1) Of The Income Tax Act 1961Mar 21, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 07, 2026
Announcement under Regulation 30 (LODR)-Credit RatingFeb 26, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 26, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 13, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 09, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 06, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 06, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 05, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 05, 2026
Unaudited Financial Results (Standalone And Consolidated) For The Third Quarter And Nine Months Ended On 31 December 2025.Feb 05, 2026
Board Meeting Outcome for For Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended On 31 December 2025.Feb 05, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 28, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 28, 2026
Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results For The Third Quarter And Nine Months Ended December 31 2025.Jan 22, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Intimation Of Receipt Of Letter From BSE Dated 06 January 2026 And NSE Dated 07 January 2026.Jan 07, 2026
Receipt Of An Order Dated 30Th December 2025 Passed By The Additional Commissioner Ranga Reddy GST Commissionerate Hyderabad U/S 74 Of The Central Goods And Services Tax Act 2017Dec 31, 2025
Closure of Trading WindowDec 29, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 19, 2025
An Order Dated 09Th December 2025 Was Passed By The Deputy Commissioner Of Commercial Taxes (Audit) Bidar DGSTO Kalaburagi U/S 73(9) Of The Integrated Goods And Services Tax Act 2017.Dec 11, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 08, 2025
An Order Dated 06Th December 2025 Has Been Passed By The Joint Commissioner Of Commercial Taxes (Appeals) Kalaburagi Under Section 107(11) Of The Karnataka Goods And Services Tax Act 2017.Dec 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 25, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 23, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan Healthcare Fund Direct-Growth
1.47%
-10000
-0.31%
-0.56%
Zerodha Nifty MidSmallcap400 50:50 Index Fund Direct-Growth
0.39%
291
0.39%
0.39%
UTI Nifty500 Shariah Index Fund Direct-Growth
0.26%
200
0.00%
0.02%
JioBlackRock Sector Rotation Fund Direct-Growth
0.10%
136
0.00%
0.01%
DSP Nifty Smallcap 250 Index Fund Direct-Growth
0.74%
108
-0.03%
0.03%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.07%
15
0.00%
0.01%
Navi Nifty MidSmallcap 400 Index Fund Direct-Growth
0.25%
11
0.00%
0.01%
DSP Nifty 500 Index Fund Direct-Growth
0.08%
7
0.01%
0.01%
JioBlackRock Nifty Smallcap 250 Index Fund Direct-Growth
0.74%
5
-0.05%
0.02%
ITI Mid Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Aditya Birla Sun Life Small Cap Fund Direct-Growth
2.62%
0
0.00%
-0.19%
Aditya Birla Sun Life Multi-Cap Fund Direct-Growth
1.45%
0
0.00%
-0.03%
Aditya Birla Sun Life Nifty Smallcap 50 Index Fund Direct-Growth
2.02%
0
0.00%
-0.15%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
2.20%
0
0.00%
0.10%
Aditya Birla Sun Life Retirement Fund - The 40s Plan Direct-Growth
1.42%
0
0.00%
0.04%
Kotak Healthcare Fund Direct-Growth
3.02%
0
0.00%
-0.06%
Angel One Nifty Total Market Index Fund Direct-Growth
0.07%
0
0.00%
0.00%
Axis Flexi Cap Fund Direct-Growth
0.96%
0
0.00%
0.00%
Axis India Manufacturing Fund Direct-Growth
0.40%
0
0.00%
-0.07%
Axis Innovation Fund Direct-Growth
1.64%
0
0.00%
-0.05%
Axis Multicap Fund Direct-Growth
0.90%
0
0.00%
-0.02%
Axis Nifty 500 Index Fund Direct-Growth
0.08%
0
0.00%
0.00%
Axis Nifty Smallcap 50 Index Fund Direct-Growth
2.02%
0
0.00%
-0.16%
Axis Small Cap Fund Direct-Growth
1.47%
0
0.00%
-0.06%
Bandhan Balanced Advantage Fund Direct-Growth
0.00%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
62.14
ATR(14)
Less Volatile
48.36
STOCH(9,6)
Overbought
84.91
STOCH RSI(14)
Oversold
12.41
MACD(12,26)
Bullish
0.43
ADX(14)
Weak Trend
18.30
UO(9)
Bearish
62.31
ROC(12)
Uptrend And Accelerating
7.03
WillR(14)
Overbought
-10.53